SEA0400

SEA0400 is an inhibitor of Calcium Channels and NCX and related targets used in studies of MAPK / ERK Signaling and Immune Signaling and related signaling programs. It is especially relevant in cardiovascular, cell signaling, and inflammation models, where defined compound exposure can be linked to mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and cytokine-mediated signaling and inflammatory effector responses.

By inhibiting Calcium Channels and NCX and related targets, SEA0400 can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and cytokine-mediated signaling and inflammatory effector responses. The ion channel annotation adds relevance to electrophysiology, ion-flux, and membrane-potential studies, together with downstream-response mapping in the same experimental setting. In cardiovascular, cell signaling, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Calcium Channels and NCX and related targets
• Pathway perturbation studies connected to MAPK / ERK Signaling and Immune Signaling and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Electrophysiology, ion-flux, and membrane-potential studies

Overall, SEA0400 is appropriate when a defined chemical perturbant is needed to connect Calcium Channels and NCX and related targets with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular, cell signaling, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.